Who We Are

Pharmazac is one of the fastest growing pharmaceutical firms in Greece and a top investor in Rx and healthcare solutions. It has been awarded several prizes for its performance and recently has been characterised as one of the Greek economy gems.

Pharmazac business units and activities cover the full spectrum of pharmaceutical services as it operates in-house the development, regulatory, medical promotion, manufacturing and logistics of medicinal and healthcare products.

The expanding assets today include installations of 35.000 m² (8.000 under development), a portfolio of more than 120 licensed brands in Greece and a growing basket of international registrations as well as investments in top-tier projects.

Moreover, a widening number of partnerships with established international companies (General Electric Healthcare, MRP, Synthaverse, Servier, etc.) guarantees a swiftly growing reputation and exposure. Pharmazac current developments and portfolio are expanding with a pipeline of more than 15 products to be completed by 2030.

Our History

Establishment of Pharmazac S.A.
Pharmazac Timeline Preview
1986

Founding of Pharmazac S.A.

1992

Representation of multinational companies

2006

Operation of our modern logistics centre in Athens

2007

Launch of our first generics in Greece

2019

Operation of our state-of-the-art GMP R&D centre

2022

Start of export activity

2023

Inauguration of our radiopharmaceutical production site in Lamia

2024

Inauguration of our pharmaceutical production site and R&D centre in Keratea

2025

Relocation of our headquarters to Keratea

Our Philosophy

At Pharmazac, our philosophy is built on a simple belief: meaningful healthcare progress comes from investing in people, science, quality, and innovation. For over four decades, we have worked to transform knowledge into therapeutic and diagnostic solutions that improve patients’ lives in Greece and around the world.

We combine entrepreneurial agility with the highest standards of quality governance, continuously investing in research and development, advanced manufacturing, and digital excellence. Our commitment to innovation is matched by our dedication to reliability, ensuring that every product and service reflects our responsibility to patients, healthcare professionals, and society.

We believe sustainable growth is achieved through long-term partnerships, scientific expertise, and the continuous development of our people. By expanding our capabilities, supporting local communities, and strengthening access to high-quality healthcare solutions, we aim to create lasting value for future generations.

Driven by our vision and guided by our values, we continue to shape a future where innovation, quality, and human care go hand in hand.

Our Numbers

40 years of history

Established in 1986, Pharmazac has recently celebrated its 40th birthday, marking a history in pharmaceuticals and diagnostics.

850 SKUs launched

850 SKUs launched to date, spanning prescription medicines, generics, diagnostics, and radiopharmaceuticals.

60 countries of presence

Our products are marketed in over 60 countries worldwide through a combination of subsidiaries, distributor networks, and licensing partnerships with pharmaceutical companies in international markets.

21 in-house developments

Twenty-one products developed in-house, from formulation through to approval, reflecting sustained investment in research and development.

3 operational sites

Pharmazac maintains R&D, logistics, manufacturing and QC operations across three sites in Greece (Athens, Keratea and Lamia) as well as two commercial offices.